在CDK4和6抑制剂的进步:转变乳腺癌治疗方法
Sonia Santander Ballestín1, María Abadía Labena2, Ana Avedillo-Salas3
1Department of Pharmacology, Phisiology, and Legal-Forensic Medicine, Faculty of Health and Sports Sciences, University of Zaragoza, 22001 Huesca, Spain.
Cancers
|March 13, 2025
概括
在内分泌治疗中添加循环素依赖性激酶4和6 (CDK4/6) 抑制剂显著改善了晚期HER2-阴性乳腺癌的结果. 这种新的治疗方法提供了更好的生存率和更少的无化疗间隔,具有较低的毒性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺癌是全球女性癌症死亡的主要原因之一.
- 循环素依赖性激酶4和6 (CDK4/6) 抑制剂向细胞周期进展.
- 这些抑制剂是一种新的辅助疗法,用于晚期或转移的HER2-阴性,激素受体阳性乳腺癌.
研究的目的:
- 评估CDK4/6抑制剂与标准内分泌疗法相结合的疗效和安全性.
- 分析最近关于乳腺癌治疗中CDK4/6抑制剂的文献.
主要方法:
- 科学文献的系统审查.
- 分析的重点是过去五年内发表的研究.
- 评估无进展生存率,总生存率和无化疗间隔.
主要成果:
- 组合疗法显著改善了无进展生存期 (PFS).
- 整体存活率和无化疗间隔也得到改善.
- 与化疗相比,CDK4/6抑制剂的毒性较低.
结论:
- CDK4/6抑制剂加上内分泌治疗是晚期HER2-阴性乳腺癌的新标准.
- 这种组合比单独的荷尔蒙疗法提供了更好的生存益处.
- 需要进一步的研究来理解和克服治疗耐药性机制.
相关概念视频
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Positive Regulator Molecules
5.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K


